Exploration of novel biomarkers for neurodegenerative diseases using proteomic analysis and ligand-binding assays
Annalena Kenzelmann, Christina Boch, Ronny Schmidt, Mario Richter, Michael Schulz
This study combines proteomic screening and ligand-binding assays to identify potential biomarkers for neurodegenerative diseases in CSF and plasma samples.
Biomedicines · Dec 9, 2024Peer-reviewedNeuroscience